DIA 2023: Cal Collins Discusses SMART on FHIR and Supply Chains

Despite challenges surrounding communication overload, drug shortages, and cybersecurity risks, this term is revolutionizing medication management and patient care through the use artificial intelligence and predictive forecasting.

Nicholas Saraceno offers an overview of the legislation and how it impacts the pharma supply chain.

The program intends to address supply chain challenges surrounding product safety, traceability, and counterfeiting.

Rob Sobie outlines the importance of supply chain transparency for the benefit of patients.

Pharma Commerce was on the road extensively throughout 2024, and plenty of insight was gathered along the way.

The Drug Supply Chain Security Act was a major coverage area for Pharma Commerce in 2024.